Sanofi unveils heart disease partnership with MyoKardia
September 17, 2014 at 01:22 AM EDT
PARIS, Sept 17 (Reuters) - French drugmaker Sanofi announced on Wednesday a partnership with U.S.-based MyoKardia to develop therapies for patients with genetic heart diseases.